Chemically Modified Extracellular Vesicles and Applications in Radiolabeling and Drug Delivery
Extracellular vesicles (EVs) have been exploited as bio-inspired drug delivery systems (DDS) in the biomedical field. EVs have more advantages than synthetic nanoparticles: they are naturally equipped to cross extra- and intra-cellular barriers. Furthermore, they can deliver functional biomolecules...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Book |
| Published: |
MDPI AG,
2022-03-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
| LEADER | 00000 am a22000003u 4500 | ||
|---|---|---|---|
| 001 | doaj_7f45d4fd8f1a45f5be2a1cde41175f8f | ||
| 042 | |a dc | ||
| 100 | 1 | 0 | |a Elisa-Racky N'Diaye |e author |
| 700 | 1 | 0 | |a Nicola Salvatore Orefice |e author |
| 700 | 1 | 0 | |a Catherine Ghezzi |e author |
| 700 | 1 | 0 | |a Ahcène Boumendjel |e author |
| 245 | 0 | 0 | |a Chemically Modified Extracellular Vesicles and Applications in Radiolabeling and Drug Delivery |
| 260 | |b MDPI AG, |c 2022-03-01T00:00:00Z. | ||
| 500 | |a 10.3390/pharmaceutics14030653 | ||
| 500 | |a 1999-4923 | ||
| 520 | |a Extracellular vesicles (EVs) have been exploited as bio-inspired drug delivery systems (DDS) in the biomedical field. EVs have more advantages than synthetic nanoparticles: they are naturally equipped to cross extra- and intra-cellular barriers. Furthermore, they can deliver functional biomolecules from one cell to another even far away in the body. These advantages, along with obtained promising in vivo results, clearly evidenced the potential of EVs in drug delivery. Nevertheless, due to the difficulties of finding a chemical approach that is coherent with EVs' rational clinical therapeutic use, those in the drug delivery community are expecting more from EVs' use. Therefore, this review gathered knowledge of the current chemical approaches dealing with the conjugation of EVs for drugs and radiotracers. | ||
| 546 | |a EN | ||
| 690 | |a extracellular vesicles | ||
| 690 | |a nanoparticles | ||
| 690 | |a drug delivery | ||
| 690 | |a radiolabeling | ||
| 690 | |a Pharmacy and materia medica | ||
| 690 | |a RS1-441 | ||
| 655 | 7 | |a article |2 local | |
| 786 | 0 | |n Pharmaceutics, Vol 14, Iss 3, p 653 (2022) | |
| 787 | 0 | |n https://www.mdpi.com/1999-4923/14/3/653 | |
| 787 | 0 | |n https://doaj.org/toc/1999-4923 | |
| 856 | 4 | 1 | |u https://doaj.org/article/7f45d4fd8f1a45f5be2a1cde41175f8f |z Connect to this object online. |